Literature DB >> 34453153

Mitomycin C plus cytosine arabinoside for NMIBC.

Timothy Thomas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34453153     DOI： 10.1038/s41585-021-00516-7

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Intravesical mitomycin C (MMC) and MMC + cytosine arabinoside for non-muscle-invasive bladder cancer: a randomised clinical trial.

Authors:  Yasuyoshi Miyata; Toshifumi Tsurusaki; Yasushi Hayashida; Yushi Imasato; Kosuke Takehara; Daiyu Aoki; Masaharu Nishikido; Junichi Watanabe; Kensuke Mitsunari; Tomohiro Matsuo; Kojiro Ohba; Keisuke Taniguchi; Hideki Sakai
Journal:  BJU Int       Date:  2021-08-24       Impact factor: 5.969
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.